![Stephen Prior](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Stephen Prior
Keine laufenden Positionen mehr
Vermögen: 327 927 $ am 31.08.2026
Profil
Stephen D.
Prior is the founder of DynPort Vaccine Co. LLC.
Former jobs include Executive Director at National Defense University from 2006 to 2024, Chief Strategy Officer at AN2 Therapeutics, Inc., and Chief Scientific Officer at Exponential Biotherapies, Inc. Education includes a doctorate from the University of Warwick and an undergraduate degree from the University of Kent.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 06.01.2026 | 59’086 ( 0.16% ) | 327 927 $ | 31.08.2026 |
Ehemalige bekannte Positionen von Stephen Prior
| Unternehmen | Position | Ende |
|---|---|---|
National Defense University
 National Defense University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01.12.2024 |
DynPort Vaccine Co. LLC
 DynPort Vaccine Co. LLC Miscellaneous Commercial ServicesCommercial Services Provides biopharmaceutical, vaccine and medical product development & licensure services | Gründer | - |
| AN2 THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Exponential Biotherapies, Inc.
 Exponential Biotherapies, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Stephen Prior
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
10
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Exponential Biotherapies, Inc.
Exponential Biotherapies, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics | Health Technology |
DynPort Vaccine Co. LLC
DynPort Vaccine Co. LLC Miscellaneous Commercial ServicesCommercial Services Provides biopharmaceutical, vaccine and medical product development & licensure services | Commercial Services |
National Defense University
National Defense University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Warwick
 University of Warwick Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Kent
 University of Kent Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AN2 Therapeutics, Inc.
 AN2 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics | Health Technology |
